Eubelius assists ViroVet on its succesful Series C financing round

News
24 June 2022
Corporate and M&A

Congratulations to ViroVet on its successful Series C financing round. Since the company was founded, almost EUR 20,000,000 of capital has been raised.

ViroVet is active in the development of breakthrough and innovative technologies for the control and treatment of viral diseases in livestock.

We are proud to have assisted ViroVet with this transaction.

The Eubelius team involved in the transaction consisted of Matthias Wauters, Fréderic Van Campe and Odile Watté.

Matthias

Matthias Wauters

Partner

Fréderic Van Campe

Counsel

Odile Watté

Attorney

Eubelius assists the shareholders of hsbcad in connection with the sale to Maguar Capital

Eubelius, together with Monard Law, has assisted the shareholders of hsbcad, a leading provider of offsite wood construction software, in...

Abolition of the quasi-immunity of the executing agent: Directors beware!

On 1 February 2024, the law introducing Book 6 of the Civil Code (the CC) was passed. On 1 January 2025, Book 6 will enter into force.

Eubelius advises TDL Group in the sale of its Fresh Logistics business to STEF Group

Eubelius has successfully assisted TDL Group in the sale of its Fresh Logistics business to listed French STEF Group, the European...